@article { author = {Radmanesh, M and Shafiei, S}, title = {Psychopathology of psychocutaneous disorders}, journal = {Iranian Journal of Dermatology}, volume = {5}, number = {3}, pages = {2-6}, year = {2002}, publisher = {Iranian Society of Dermatology}, issn = {2717-0721}, eissn = {2717-0721}, doi = {}, abstract = {Background: A high percentage of the patients referred to dermatologic clinics are either suffer from self inflicted disorders or from misinterpretation about their own health and organ integrity and or may suffer from different skin sensations including itching, pain, and burning; all of which may develop as a result of their underlying psychopathologies. Objective: Identification of underlying psychopathology of psychocutaneous disorders. Patients and Methods: 109 dermatologic patients who clinically diagnosed as psychocutaneous disorders referred to psychiatric clinic for identification of their mood, personality and thought disorders. The impression of psychocutaneous disorder was made according to clinical interview and physical examinations in dermatology office. A semi-structured interview based on DSM-IV criteria performed on all patients to evaluate their mood, personality and thought. They also filled the Beck’s and Tailor inventories for further evaluation of their possible depression and anxiety. Results: 107 out of 109 cases studied, suffered from mood disorders including anxiety, depression or a combination of them. Of the remaining two cases one suffered from attention deficit hyperactivity disorder (ADHD) and the second one had no psychiatric disorder. 17 out of these 107 cases also suffered from personality disorder and 3 cases had delusional thoughts. Conclusion: All psychocutaneous patients may suffer from one or more psychiatric disorders which should be identified and approached properly.}, keywords = {Psychocutaneous disorders,psychopathology,Mood disorders,Personality disorders,Thought disorders}, url = {https://www.iranjd.ir/article_98445.html}, eprint = {https://www.iranjd.ir/article_98445_6eb63e0b04c7d533c0bb29e29c69365c.pdf} } @article { author = {Yaghoobi, R and Rafiei, R and Savad Dar, F and Latifi, SM}, title = {Malignant Melanoma in Khouzestan: Study of 62 cases}, journal = {Iranian Journal of Dermatology}, volume = {5}, number = {3}, pages = {7-14}, year = {2002}, publisher = {Iranian Society of Dermatology}, issn = {2717-0721}, eissn = {2717-0721}, doi = {}, abstract = {Background: Malignant melanoma is the leading cause of death among skin cancers in western countries. However, the incidence, histologic subtypes, and tumor behaviors are quite different in Asians and western populations. Objective: This study was designed to survey the clinicopathological aspects of malignant melanoma among Khouzestan people. Patients and Methods: In a retrospective study 62 patients (28 women, mean age 53.80±14.1, and 34 men, mean age 55.9±15.8) were diagnosed as melanoma in Khouzestan province, southwest of Iran during 1990-2000. The analyzed data included sex, age at diagnosis, location and histologic subtypes. Results: Malignant melanoma was found to be more common in men than women, in the approximate ratio of 5 to 4. From 62 cases of malignant melanoma, 59.67% were cutaneous, 19.35% metastatic in lymph nodes, 11.29% ocular, 4.83% gastrointestinal tract, 3.22% mucosal, and 1.61% inner ear and mastoid. The majority of cases were unclassified malignant melanoma (30.64%), followed by nodular melanoma (27.41%), metastatic malignant melanoma (24.19%), acral lentiginous melanoma (12.9%), and lentigo maligna melanoma (4.84%), respectively. Conclusion: Although malignant melanoma is a rare tumor in Khouzestan, further studied are necessary to analyze present and future trends of melanoma, accurately. Ongoing and new prevention and control strategies may be mandatory to curtail the melanoma outbreak.}, keywords = {Malignant Melanoma,Khouzestan,retrospective study}, url = {https://www.iranjd.ir/article_98446.html}, eprint = {https://www.iranjd.ir/article_98446_2a9b26ed18e6b02cc1617c6794b0e3f0.pdf} } @article { author = {Nabaei, B and Safizadeh, H and Halaji, Z}, title = {A study concerning quality of life among patients with Psoriasis compared with general population}, journal = {Iranian Journal of Dermatology}, volume = {5}, number = {3}, pages = {15-21}, year = {2002}, publisher = {Iranian Society of Dermatology}, issn = {2717-0721}, eissn = {2717-0721}, doi = {}, abstract = {Background: The reduction of disability caused by psoriasis is an important issue in dermatology. It is thus important to assess the patients’ appraisal of their quality of life. Objective: The aim of the present study was to assess quality of life among patients with psoriasis and to compare these estimates with general population. Patients and Methods: In this cross-sectional study, 55 patients and 55 control subjects were interviewed in Tehran Razi hospital. Quality of life was assessed by SF-36 and PDI questionnaires. Results: After score calculation in any domain of SF-36, it was seen that psoriasis patients reported significantly lower scores than the normal control subjects in all scales, except for physical functioning. The greatest difference was found in social functioning. The smallest difference was noticed in vitality. The psoriasis disability index score (PDI) was negatively correlated with all of the eight of the SF-36 health measures in psoriatic patients. Conclusion: These results show that psoriasis patients report poorer quality of life than general population. Therefore, in the case of these patients one most pay attention to the impact of this disease on different life domains.}, keywords = {Psoriasis,Quality,Vitality}, url = {https://www.iranjd.ir/article_98447.html}, eprint = {https://www.iranjd.ir/article_98447_378a43788cc5f5c79d29cc4d5fa08919.pdf} } @article { author = {Asilian, A and Omid Ghaemi, MR and Momeni, A and Iraji, F}, title = {Effect of vitamin E and Acitretin combination on decreasing side effects of Acitretin}, journal = {Iranian Journal of Dermatology}, volume = {5}, number = {3}, pages = {22-28}, year = {2002}, publisher = {Iranian Society of Dermatology}, issn = {2717-0721}, eissn = {2717-0721}, doi = {}, abstract = {Background: Acitretin therapy is frequently associated with reversible, dose-related side effects. Recent studies claimed that combining vitamin E with high-dose isotretinoin reduced isotretinoin-induced side effects. Objective: The purpose of this clinical trial study was to determine the effect of a fixed or adjusted dose of vitamin E on the side effects of acitretin. Patients and Methods: Fifty five subjects were randomly assigned to one of the two treatment programs including with acitretin (0.7-1 mg/kg/day) together with either vitamin E (13 IU/kg/day) or alone for 3 months. The incidence of side effects of acitretin in two groups were assessed and compared. Results: The study was completed in thirty-nine patients. Vitamin E did not decreased the incidence of side effects associated with acitretin. Conclusion: Vitamin E did not significantly ameliorate retinoid side affects when combined with 0.7-1 mg/kg of acitretin in treatment of skin disorders.}, keywords = {Retinoid,Vitamin E,acitretin}, url = {https://www.iranjd.ir/article_98449.html}, eprint = {https://www.iranjd.ir/article_98449_54c0e54396586698d1859f31cfce6116.pdf} } @article { author = {Yaghoobi, R and Sina, N and Latifi, SM}, title = {Skin manifestations of patients with chronic renal failure on long-term hemodialysis}, journal = {Iranian Journal of Dermatology}, volume = {5}, number = {3}, pages = {29-34}, year = {2002}, publisher = {Iranian Society of Dermatology}, issn = {2717-0721}, eissn = {2717-0721}, doi = {}, abstract = {Background: There are several reports of different cutaneous manifestations in patients with chronic renal failure (CRF) managed by repeated hemodialysis, in the literature. Objective: This study was conducted to evaluate the prevalence of skin manifestations in patients suffering from CRF who are on long-term hemodialysis. Patients and Methods: The skin manifestations of 108 CRF patients who underwent hemodialysis in Hemodialysis Center of Ahwaz University of Medical Sciences during the years 2000-2001 were studied by a dermatologist. The duration of dialysis in these patients was between 15 days and 101 months (Mean: 17.04 mo.). Results: All of the patients had at least one cutaneous sign or symptom. The most common finding was skin discoloration (77.7%). Other findings were nail changes (75%), xerosis (60.1%), Pruritus (58.3%), ecchymosis (25.9%) and acquired perforating disorder (1.8%). There was no significant correlation between these findings and sex, age, duration of dialysis and underlying disease. Conclusion: Cutaneous manifestations are common findings among CRF patients who are on long-term hemodialysis and dialysis possibly can affect the frequency of these findings.}, keywords = {Chronic renal failure,Hemodialysis,Skin manifestations}, url = {https://www.iranjd.ir/article_98450.html}, eprint = {https://www.iranjd.ir/article_98450_64e016fb3a0e18a96bd8426517058bfb.pdf} } @article { author = {Mirshams Shahshahani, M and Fathabadi, M and Ehsani, AH and Zakeri, M}, title = {Efficacy of 20% Aluminium Chloride Hexahydrate in the treatment of multiple eccrine Hidrocystoma}, journal = {Iranian Journal of Dermatology}, volume = {5}, number = {3}, pages = {35-40}, year = {2002}, publisher = {Iranian Society of Dermatology}, issn = {2717-0721}, eissn = {2717-0721}, doi = {}, abstract = {Background: Eccrine hydrocystomas are essentially eccrine sweat gland retention cyst located in the dermis that clinically presents as small translucent cystic swelling. Objective: This study was designed to evaluate the efficacy and safety of 20% aluminum chloride hexahydrate in absolute alcohol in the treatment of eccrine hydrocystoma. Patients and Methods: In a randomized, double-blind, placebo controlled clinical trial, 33 patients with multiple eccrine hydrocystoma referred to Tehran Razi hospital during the summer of 2000, were divided in two groups: One group received 20% aluminum chloride hexahydrate in absolute alcohol and the other one received only absolute alcohol. The patients applied the drugs to dried skin at bedtime, and washed the area in the morning. Results: Excellent or good therapeutic effects (More than 50% of improvement) were achieved in 87.5% of patients who applied 20% aluminum chloride hexahydrate but only in 17.6% of patients in control group (P<0.0001). The mean age in the first group was 42.6 years and in placebo group 45.4 years. Side effects in the first group included pruritus, burning (37.5%), xerosis and scaly (31.2%) and erythema (25%), in control group the rate of these side effects were 23.5%, 17.6%, and 11.7% consequently. Conclusion: 20% aluminum chloride hexahydrate solution is an effective and safe topical agent in the treatment of multiple eccrine hydrocystomas.}, keywords = {Eccrine hidrocystoma,Aluminium chloride hexahydrate,Double blind clinical trial}, url = {https://www.iranjd.ir/article_98451.html}, eprint = {https://www.iranjd.ir/article_98451_811df3b685fc3c05370073fd11582ac3.pdf} } @article { author = {Pazeshkpoor, F and Soleimani, M}, title = {Langerhans cell Histiocytosis: Seborrheic dermatitis-like skin signs and polypoid lesion of external ear in a 41-year-old man (Case report)}, journal = {Iranian Journal of Dermatology}, volume = {5}, number = {3}, pages = {41-44}, year = {2002}, publisher = {Iranian Society of Dermatology}, issn = {2717-0721}, eissn = {2717-0721}, doi = {}, abstract = {Langerhans cell histiocytosis includes a broad spectrum of clinical diseases resulted from proliferation and tissue infiltration of differentiated langerhans cells. This term includes Letterer-siwe disease, Hand-Schuller-Christian disease, eosinophilic granuloma and congenital reticulohistiocytosis that are more common in children than adults. This entity has recently been classified into restricted and extensive forms according to the number of involved organs. We report here in a 41-year-old man who developed Langerhans histiocytosis and presented with seborrheic dermatitis-like skin signs and external ear polypoid lesion without other organ involvement.}, keywords = {langerhans cell histiocytosis,seborrheic dermatitis,External Ear}, url = {https://www.iranjd.ir/article_98452.html}, eprint = {https://www.iranjd.ir/article_98452_e8359ae9635f5c7ceb74e2f12523c145.pdf} } @article { author = {Alavian, SM and Shokoohi, A}, title = {Vitiligo Complicating chronic Hepatitis B patients treated with α-Interferon (Report of two cases)}, journal = {Iranian Journal of Dermatology}, volume = {5}, number = {3}, pages = {45-49}, year = {2002}, publisher = {Iranian Society of Dermatology}, issn = {2717-0721}, eissn = {2717-0721}, doi = {}, abstract = {α-Interferon is an antiviral agent used in treatment of chronic hepatitis B. Triggering of the underlying autoimmune disease or exacerbation of pre-existing auto immune disease is documented with α-interferon, but there are few reports about occurrence of autoimmune disorders such as systemic lupus erythematosus, Vitiligo, hypo and hyperthyroidism after administration of α-interferon in the literature. We report here in two cases of chronic hepatitis B treated with a-interferon, who developed Vitiliginous lesions. These lesions disappeared within 3 to 6 months after discontinuing α-interferon therapy. Until now, the occurrence of vitiligo after administration of α-interferon in chronic hepatitis B has not been reported.}, keywords = {Chronic hepatitis B,α Interferon,Vitiligo}, url = {https://www.iranjd.ir/article_98448.html}, eprint = {https://www.iranjd.ir/article_98448_e1773b56adf91bda20cf296dd5ee020e.pdf} }